New award for losartan potassium tablets with xlcare pharmaceuticals, INC. Period of performance is september 24, 2020 to september 23, 2021 with 4 one-year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79720D0038
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$143,284,854.50
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The single-award IDC has a ceiling value of $143,284,854.50 and a period of performance from September 24, 2020 to September 23, 2025, with a one-year base period and four one-year option periods.

The contract is for the supply of losartan potassium tablets in various pack sizes to support the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The estimated annual requirements for the nine line items range from 33,710 to 547,370 bottles. This procurement was conducted as an unrestricted, full and open competition. The contract items will be distributed through the VA's and DoD's respective pharmaceutical prime vendor programs.

Transactions

Action Obligated Date
Exercise an Option P00006 · Exercise the fourth and final option year for losartan potassium tablets contract 36E79720D0038 with xlcare pharmaceuticals INC. With no price changes $0
Supplemental Agreement for work within scope P00005 · Change timeframe for the submission of quarterly sales reports and cost recovery fee to 30 calendar days after end of each fiscal quarter. $0
Exercise an Option P00004 · Exercise option year 3 effective sept. 24, 2023 to sept. 23, 2024 for losartan potassium tablets with xlcare pharmaceuticals, INC. With price changes. $0
Other Administrative Action P00003 · Incorporation of drug supply chain security act (DSCSA) language $0
Exercise an Option P00002 · Exercise option year 2 for losartan potassium tablets with xlcare pharmaceuticals, INC. Period of performance is september 24, 2022 to september 23, 2023 with… $0
Exercise an Option P00001 · Exercise option year 1 for losartan potassium tablets with xlcare pharmaceuticals, INC. Period of performance is september 24, 2021 to september 23, 2022 with… $0
Original award $0

Quick answers

Who was awarded contract 36E79720D0038?

36E79720D0038 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on September 24, 2020.

How much is contract 36E79720D0038 worth?

36E79720D0038's own ceiling is $143,284,855.

Who can order from contract 36E79720D0038?

36E79720D0038 is a single award indefinite delivery contract.

Was contract 36E79720D0038 competed?

The extent of competition for 36E79720D0038 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV